The global Companion Animal Specialty Drugs Market is anticipated to reach a valuation of US$ 56,828.56 Mn by 2032, with the market growing at an average CAGR of 4.21% from 2022 to 2032. Currently valued at US$ 37,624.67 Mn, the companion animal specialty drugs market is driven by the growing adoption of pets and the …
Category Archives: Healthcare Trends
Saudi Arabia Pharmaceutical Market is expected to flourish at a CAGR of 9% by 2032
The Saudi Arabia Pharmaceutical Market is expected to be worth US$ 5,209.5 million by the end of 2022, growing at a CAGR of 9.6% during the forecast period (2022–2032). Due to the country’s fast-growing population and significant influx of ex-pats, the pharmaceutical business in Saudi Arabia is anticipated to continue its high growth momentum. Pharmaceuticals …
Wearable Medical Devices Market is anticipated to reach a valuation of US$ 73.48 Billion by 2032 | FMI Study
Wearable Medical Devices Market is predicted to reach US$ 73.48 billion in 2032, growing at a 28.1% CAGR. The wearable medical device market is anticipated to rise as a result of a growing population and an increase in chronic diseases. As a result of regulatory initiatives, the expansion of the healthcare industry, and an increase …
Laboratory Information Systems (LIS) Market is expected to reach a valuation of US$ 4.2 Million by 2032 | FMI
The global Laboratory Information Systems (LIS) Market is expected to be worth US$ 1.8 billion by 2021. Sales are expected to increase at a 10.2% CAGR, bringing the market size to US$ 1.9 billion by 2022. Sales are expected to grow at a healthy 10.2% CAGR over the assessment period, thanks to the aforementioned factors. …
Increasing Applications in Hospital & Retail Pharmacies will Propel Pharmacy Automation Systems Market to US$ 10.6 Billion in 2032
The global pharmacy automation systems market is projected to reach a value of about US$ 10.6 Bn by 2032, with the market growing at a strong CAGR of 8.0% from 2022 to 2032. Valued at US$ 4.6 Mn in 2021, the target market will likely reach US$ 4.9 Bn in 2022. The elevated usage of …
Global Drug Eruptions Treatment Market to reach US$ 7.1 billion by 2033, Antihistamines to account for 41% of all Treatments | FMI Study
The global drug eruptions market is estimated to be valued US$ 3.89 billion in fiscal year 2023, compared to US$ 3.66 billion in fiscal year 2022. The global market is anticipated to increase steadily from 2023 to 2033 at a 6.2% CAGR, reaching US$ 7.1 billion by the end of that year. Skin sensitivity to …
The Global Eosinophilic Granulomatosis with Polyangiitis Treatment Market Is Expected to Register Growth at 5.2% CAGR through 2033 | FMI Study
In 2023, Eosinophilic Granulomatosis with Polyangiitis Treatment Market is expected to reach a value of US$ 173.8 million at a CAGR of 5.2%. Healthcare technology advancements are expected to drive the market to US$ 288.5 million by 2033. The growing occurrences of churg strauss syndrome and other allergic reactions and asthma, rising geriatric population, and …
Promising Results from Gene Delivery and Enzyme Replacement Therapies to Revolutionize the USA Fucosidosis Therapeutics Market | FMI Predicts 25% of Revenue to Come from North America
According to Future Market Insights, North America is anticipated to hold around 25% share in the global fucosidosis therapeutics market during the forecast period. Within North America, the USA fucosidosis therapeutics market is predicted to exert a domineering influence throughout the projected period. Advanced therapies such as gene therapy and enzyme replacement therapy (ERT) are …
Eisenmenger Complex Management Market to reach US$ 12.9 billion in 2033, Endothelin Receptors to account for 48.1% of all Drugs | FMI Study
The global Eisenmenger complex management market is expected to surpass an impressive valuation of US$ 7.7 billion in 2023 and is projected to reach US$ 12.9 billion by 2033, growing at a CAGR of 5.3%. Generally, the treatment includes relieving the symptoms and associated co-morbidities. Medications such as calcium channel blockers, antiarrhythmic agents, and blood …
Peptide Drug Conjugates Market is projected to expand at a 20% value CAGR by 2033
The global peptide drug conjugates market is expected to be worth US$ 861.12 million in 2023 and US$ 5,331.83 million by 2033. Over the forecast period of 2023 to 2033, the predicted growth rate is about 20%. The growth of the market is attributed to the global upsurge in cancer cases and related mortality, strong …
Continue reading “Peptide Drug Conjugates Market is projected to expand at a 20% value CAGR by 2033”